ASND receives positive CHMP opinion for navepegritide in children with achondroplasia
TransCon CNP (navepegritide), administered once weekly, received a positive opinion from the CHMP for treating achondroplasia in children.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.